Looking for a Treatment for the Early Stage of Alzheimer’s Disease: Preclinical Evidence with Co-Ultramicronized Palmitoylethanolamide and Luteolin

Background: At the earliest stage of Alzheimer’s disease (AD), although patients are still asymptomatic, cerebral alterations have already been triggered. In addition to beta amyloid (Aβ) accumulation, both glial alterations and neuroinflammation have been documented at this stage. Starting treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Facchinetti, Roberta, Valenza, Marta, Bronzuoli, Maria Rosanna, Menegoni, Giorgia, Ratano, Patrizia, Steardo, Luca, Campolongo, Patrizia, Scuderi, Caterina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312730/
https://www.ncbi.nlm.nih.gov/pubmed/32471239
http://dx.doi.org/10.3390/ijms21113802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312730/
https://www.ncbi.nlm.nih.gov/pubmed/32471239
http://dx.doi.org/10.3390/ijms21113802

Ejemplares similares